CP
CORZ icon

Covenant Partners’s Core Scientific CORZ Stock Holding History

Covenant Partners’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,489
Closed -$240K – 26
2025
Q4 		$240K Sell
16,489
-29
-0.2% -$506 0.07% 114
2025
Q3 		$296K Hold
16,518
– – 0.08% 104
2025
Q2 		$282K Buy
+16,518
New +$165K 0.08% 111

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Covenant Partners's CORZ Position: Q1 2026 in Review

Covenant Partners sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 16,489 shares — an estimated $240K sold.

Covenant Partners first reported a position in CORZ in Q2 2025 and held it in 3 quarters. The position peaked at $296K in Q3 2025. 387 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Covenant Partners reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
  • Covenant Partners sold 16,489 Core Scientific shares in Q1 2026, an estimated $240K.
  • Covenant Partners first reported a position in Core Scientific in Q2 2025 and held it in 3 quarters.
  • Covenant Partners's Core Scientific position peaked at $296K in Q3 2025.
  • 387 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Covenant Partners's 13F filing for Q1 2026.